BA vs DNTH · P/E 89, rev $89.46B vs rev $6.2M
The Boeing Company (BA) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
BA currently screens at market cap $177.86B and trailing P/E 89.2. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the BA and DNTH stock pages for the full models.
Not investment advice.